Two features of an innovative hybrid closed loop system can help people improve their glucose management at all times of the day, new research has revealed.

The highly respected diabetes consultant Dr Bob Young has sadly passed away.

Taking SLGT2 inhibitors is more effective in slowing your decline in estimated glomerular filtration rates than taking DPP4 inhibitors, scientists have said.

A data tool has been developed by the GIRFT team to help trusts and systems in England to calculate the benefits of employing diabetes inpatient specialist nurses (DISNs).

Healthcare professionals with an interest in diabetes are being invited to attend an event looking at the latest updates in endocrinology and diabetes in 2024.

Diabetes healthcare professionals are being invited to enter a prestigious awards programme which rewards and shares innovative practice.

A newly published guideline is now available to equip healthcare professionals with the knowledge they need to improve the treatment of adults with diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS).

Young people with newly diagnosed type 1 diabetes using closed-loop insulin delivery are more likely to have improved glycaemic management than those on standard therapy, a study has shown.

A new guideline on how to manage blood sugar levels in people with type 2 diabetes who require enteral feeding is now available.

Diabetes inpatient teams across England are being urged to take part in a GIRFT survey to help create a snapshot of current service provision.

Research into the outcomes for people admitted with diabetic foot ulcer to hospitals which serve an ethnically diverse population has revealed the high amputation risk – 44 per cent – among its mostly Black and/or Hispanic patients.

The use of sodium-glucose cotransporter-2 inhibitors was linked with lower risk of acute kidney injury for people with type 2 diabetes and stage five chronic kidney disease, research claims.

New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D), published today in Diabetes Care and Diabetologia, has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.

The DAFNE (Dose Adjustment for Normal Eating) programme is excited to announce two new free online learning opportunities designed specifically for diabetes healthcare professionals who are not part of a DAFNE service.

The Committee for Medicine Products for Human Use (CHMP) has recommended granting marketing authorisation for Zegalogue for the treatment of severe hypoglycaemia in people with diabetes.

A top guideline on how to use technology to support diabetes care in hospital has been updated.

The Diabetes Specialist Nurse (DSN) Forum UK has raised more than £3,000 to enable healthcare teams in Sierra Leone to buy lifesaving diabetes resources.

Latest research shows an injection developed to tackle obesity cuts the risk of heart attacks and strokes, regardless of the amount of weight lost.